Latest News about MRSN

Recent news which mentions MRSN

< Previous 1 2 3 4 Next >

34 Stocks Moving In Monday's Mid-Day Session

April 18, 2022

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More

April 14, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

March 23, 2022

Looking Into Mersana Therapeutics's Return On Capital Employed

March 01, 2022

Recap: Mersana Therapeutics Q4 Earnings

February 28, 2022

Earnings Scheduled For February 28, 2022

February 28, 2022

Stocks That Hit 52-Week Lows On Friday

February 18, 2022

Stocks That Hit 52-Week Lows On Wednesday

February 16, 2022

78 Biggest Movers From Friday

February 14, 2022

12 Health Care Stocks Moving In Friday's After-Market Session

February 11, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

February 10, 2022

60 Biggest Movers From Yesterday

February 10, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

February 09, 2022

40 Stocks Moving In Wednesday's Mid-Day Session

February 09, 2022

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In

February 09, 2022

Janssen Inks Over $1B Pact For Mersana's ADC Technology In Three targets

February 03, 2022

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation

February 03, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

February 03, 2022

The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets

January 05, 2022

Mersana Therapeutics, Synaffix Expand Cancer Pact To Potential Value Exceeding $1B

November 30, 2021

Mersana Therapeutics's Return On Capital Employed Insights

November 10, 2021

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data

November 09, 2021

Mersana Highlights New Preclinical Data For XMT-2056 Cancer Settings

October 08, 2021

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

October 08, 2021

72 Biggest Movers From Yesterday

September 14, 2021

45 Stocks Moving In Monday's Mid-Day Session

September 13, 2021

60 Biggest Movers From Friday

September 13, 2021

12 Health Care Stocks Moving In Friday's Intraday Session

September 10, 2021

41 Stocks Moving In Friday's Mid-Day Session

September 10, 2021

Why Are Mersana Therapeutics Shares Trading Lower On Friday?

September 10, 2021

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.